Distinct Dendritic Cell Subsets Dictate the Fate Decision between Effector and Memory CD8+ T Cell Differentiation by a CD24-Dependent Mechanism  by Kim, Taeg S. et al.
Immunity
ArticleDistinct Dendritic Cell Subsets Dictate the Fate
Decision between Effector and Memory CD8+ T Cell
Differentiation by a CD24-Dependent Mechanism
Taeg S. Kim,1,2 Stacey A. Gorski,1,3 Steven Hahn,1 Kenneth M. Murphy,4,5 and Thomas J. Braciale1,2,3,*
1Beirne B. Carter Center for Immunology Research
2Department of Pathology
3Department of Microbiology
University of Virginia, Charlottesville, VA 22908, USA
4Department of Pathology and Immunology
5Howard Hughes Medical Institute
Washington University School of Medicine, St. Louis, MO 63110, USA
*Correspondence: tjb2r@virginia.edu
http://dx.doi.org/10.1016/j.immuni.2014.02.004SUMMARY
The contribution of different DC subsets to effector
and memory CD8+ T cell generation during infection
and the mechanism by which DCs controls these
fate decisions is unclear. Here we demonstrated
that the CD103+ and CD11bhi migratory respiratory
DC (RDC) subsets after influenza virus infection acti-
vated naive virus-specific CD8+ T cells differentially.
CD103+ RDCs supported the generation of CD8+ T
effector (Teff) cells, which migrate from lymph nodes
to the infected lungs. In contrast, migrant CD11bhi
RDCs activated CD8+ T cells characteristic of central
memory CD8+ T (CD8+ Tcm) cells including retention
within the draining lymph nodes. CD103+ RDCs ex-
pressed CD24 at an elevated level, contributing to
the propensity of this DC subpopulation to support
CD8+ Teff cell differentiation. Mechanistically, CD24
was shown to regulate CD8+ T cell activation through
HMGB1-mediated engagement of T cell RAGE. Thus,
there is distribution of labor among DC subsets in
regulating CD8+ T cell differentiation.
INTRODUCTION
Lifelong protective immunity against intracellular pathogens
such as viruses requires antigen-specific CD8+ T lymphocytes
to undergo several distinct events including clonal expansion,
acquisition of effector function, migration to the site of infection,
and self-renewal (Kaech and Wherry, 2007; Lawrence and Bra-
ciale, 2004; Williams and Bevan, 2007). The process of gener-
ating CD8+ T effector cell diversity is fine tuned by a variety of
stimuli such as TCR signaling strength and/or duration, engage-
ment of stimulatory or inhibitory receptors, and local inflamma-
tory stimuli, e.g., innate immune effector cells within secondary
lymphoid organs (Haring et al., 2006; Iezzi et al., 1998; Joshi
et al., 2007). Integration of these signals within the responding400 Immunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc.T cells leads to epigenetic modifications regulated by several
pairs of transcription factors induced during T cell activation
and guides the commitment of naive T cells into activated cells
with distinct functionalities and fates.
Recent analyses suggests that both the strength and duration
of in particular IL-2-IL-2R signaling play a critical role in regu-
lating the diversification and fate decision of activated CD8+
T cells into effector T (CD8+ Teff) cells (Kalia et al., 2010; Pipkin
et al., 2010). Prolonged IL-2 signaling promotes the development
of terminally differentiated short-lived effector cells (SLECs, typi-
cally marked by CD127loKLRG1hi), at the expense of effector
cells possessing self-renewal potential (also known as MPECs
[memory precursor effector cells], CD127hiKLRG1lo). In addition
to IL-2R signaling, inflammatory signals (i.e., IL-12 and type I
interferon) promote expression of T-bet and repression of Eomes
in the responding CD8+ T cells, resulting in differentiation toward
SLEC phenotypes (Curtsinger et al., 2003; Joshi et al., 2007;
Takemoto et al., 2006), although it is not known to the extent
this process is dependent on IL-2-IL-2R signaling. Similarly,
elevated Blimp-1 expression in CD8+ T cells receiving sustained
survival signals (i.e., marked by elevated CD25 expression)
favors the generation of SLECs by reducing Bcl-6 expression,
which in turn represses the acquisition of the MPEC phenotype
by the responding CD8+ T cells (Crotty et al., 2010; Kallies
et al., 2009; Rutishauser et al., 2009). Although dynamic interac-
tions between intrinsic and extrinsic factors fine tune CD8+ T cell
differentiation, the nature and type of signals that instruct the fate
decision of naive CD8+ T lymphocytes and the contribution of the
interaction between the responding T cell and one or more anti-
gen-presenting cell (APC) types remains ill defined.
A variety of distinct DC subsets populate the respiratory tract,
where they survey the respiratory mucosa and parenchyma for
foreign antigens including pathogenic microorganisms (Braciale
et al., 2012; de Heer et al., 2005). Upon antigen acquisition and
receipt of an activation stimulus, several subsets of lung-resident
DCs then migrate into the lung draining lymph nodes (DLNs),
where they present the antigens to naive (or memory) T cells
directed to the specific antigen. These migratory DC subsets
include CD103+CD11b+/ (CD103+) and CD103CD11bhi
(CD11bhi) DCs (Jakubzick et al., 2008; Kim and Braciale, 2009;
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migrant CD103+ and CD11bhi RDCs play a primary role in
orchestrating the induction of an adaptive immune T cell
response (Kim and Braciale, 2009), with migrant CD103+ RDCs
more potent at stimulating the activation and proliferation of
naive IAV-specific CD8+ T cells in vitro than CD11bhi RDCs.
Furthermore, selective in vivo depletion of CD103+ RDCs prior
to IAV infection resulted in markedly diminished CD8+ T cell re-
sponses in the infected lung (GeurtsvanKessel et al., 2008; Helft
et al., 2012). These findings suggested that CD103+ RDCs might
serve as the primary APCs for the induction of CD8+ T cell re-
sponses to respiratory virus infection, although other evidence
implicated the migrant CD11bhi RDC subset as the dominant
APCs for CD8+ T cell priming later in the course of infection,
i.e., at the peak of IAV replication (Ballesteros-Tato et al., 2010).
Currently, it is unknown whether these two distinct RDC
subsets have different (or complementary) roles in dictating the
course and outcome of CD8+ T cell differentiation in vivo after
exposure to a respiratory stimulus such as virus infection. In
this report, we sought to determine whether the two major sub-
sets of migrant RDCs capable of activating naive CD8+ T cells,
CD103+ RDCs and CD11bhi RDCs, differed in their capacity to
support CD8+ Teff cell differentiation in response to IAV infection.
RESULTS
Deficiency in CD103+ RDCs Resulted in Impaired CD8+
Teff Cell Accumulation in the Lungs but Not the DLNs
Batf3/ mice lack lung-resident CD103+ RDCs (Figure S1A
available online) and migrant CD103+ RDCs do not accumulate
in the draining lymph nodes (DLNs) of Batf3/ mice after IAV
infection (Figures S1B; Hildner et al., 2008).
As recently reported by Helft et al. (2012) for IAV-infected
Batf3/ mice, we also observed that the influx of IAV-specific
CD8+ Teff cells into the infected lungs over time was markedly
impaired in these infected CD103+ RDC-deficient animals both
by tetramer staining (Figure 1A) and by CD8+ Teff cell IFN-g
production (Figure 1B). Batf3/ mice displayed enhanced
morbidity (i.e., weight loss, Figure S1C) but no difference in the
number and type of lung inflammatory cells (not shown).
CD103+ RDC deficiency had no effect on infectious virus titers
or virus clearance (d11 p.i.) (Figure S1D; data not shown).
Unlike the infected lungs, we unexpectedly observed no deficit
in the accumulation of IAV-specific CD8+ T cells in theDLNs of in-
fected CD103+ RDC-deficient mice (Figures 1C and 1D). These
findings did not reflect an intrinsic property of Batf3-deficient
T cells because Batf3/ CD8+ Teff cells accumulated normally
in the lungs of reconstituted IAV-infected mixed bone marrow
(1:1,WT:Batf3/) chimeric mice (Figure S1E). Furthermore, after
transfer of WT naive OVA-specific OT-I cells responding to OT-I-
IAV infection into Batf3/ mice, the transferred OT-I cells dis-
played defective CD8+ Teff cell accumulation in the IAV-infected
lungs (and spleen) but normal CD8+ T cell accumulation in the
DLNs (Figure S1F). Further, the same pattern of defective CD8+
Teff cell accumulation in the IAV-infected lungs with normal
CD8+ T cell accumulation in the DLNs was observed in Lan-
gerin-DTR mice (GeurtsvanKessel et al., 2008) after diptheria
toxin (DTx)-mediated depletion of CD103+ RDCs prior to IAV
infection (Figures 1E and 1F). In sum, these results suggestedthat CD103+ RDCs play a prominent role in driving the differenti-
ation of activated CD8+ T cells into lung-homing Teff cells
but were not required for activated CD8+ T cell proliferation in
the DLNs.
Defective Egress of CD8+ Teff Cells from the DLNs of
Infected Batf3–/– Mice with Inefficient Activation
These findings suggested that naive IAV-specific CD8+ T cells
stimulated in the CD103+ RDC-deficient DLNs activated nor-
mally but were unable to efficiently migrate out of the DLNs to
the infected lungs during the acute phase of infection. We next
analyzed the tempo and magnitude of circulating IAV-specific
CD8+ T cells in infected WT and Batf3/ mice. IAV-specific
blood CD8+ Teff cells were markedly diminished in infected
Batf3/ mice up to d10 p.i. (Figure 2A). Comparable results
were obtained in the blood for transferred responding OT-I cells
after infection of WT and Batf3/ recipient mice (Figure S2A).
In view of the above findings, it was important to establish that
the initial activation and early proliferative expansion of IAV-spe-
cific CD8+ T cells in the DLNs of infected CD103+ RDC-deficient
mice was unaffected. To do so, we adoptively transferred CFSE-
labeled naive OT-I CD8+ T cells into WT or Batf3/ recipients
and analyzed cell division, total OT-I cell accumulation, and
viability in the DLNs at 3.5 days after IAV infection, i.e., during
initial CD8+ T cell activation and proliferation (Lawrence and Bra-
ciale, 2004). Unexpectedly, we found that the extent of T cell
proliferation (i.e., CFSE dilution) (Figure 2B) as well as the total
accumulation of proliferating OT-I cells in the DLNs (Figure 2C)
was markedly decreased in the DLNs of Batf3/ mice. This
diminished CD8+ T cell response was not due to accelerated
apoptosis of the responding CD8+ T cells in the Batf3/ DLNs
(Figure S2C). Similar results were obtained with OT-I cells in
the DLNs of CD103+ RDC-depleted infected Langerin-DTR
mice (data not shown). Also, CD8+ Teff cells in the Batf3-defi-
cient infected lungs did not demonstrate accelerated apoptosis
(Figure S2D), and active division by lung-resident CD8+ Teff cells
was comparable in WT and Batf3/ recipients (Figure S2E).
These results suggested that naive CD8+ T cells could initially
activate and proliferate in the CD103+ RDC-deficient DLNs but
did so suboptimally. The ‘‘normal’’ number of responding CD8+
T cells in the DLNs of infected CD103+ RDC-deficient mice
at d7–d8 p.i. (Figures 1C and 1D) most probably reflects the
inability of these responding suboptimally stimulated CD8+
T cells to efficiently egress from the DLNs during the acute
(effector) phase of the host response to infection, resulting in
their progressive accumulation in the DLNs. Thus, the stimula-
tion of naive CD8+ T cells by CD103+ RDCs in the DLNs may
be necessary for the activated proliferating T cells to acquire
an essential property of the CD8+ Teff cells, that is, the capacity
to leave the LNs and ultimately home to the site of infection.
Impact of Stimulation by CD103+ RDCs on the
Phenotypic Profile of CD8+ T Effector Cells
We next examined early T cell activation markers and markers
characteristic of developing CD8+ Teff cells in specific CD8+
T cells (adoptively transferred OT-I cells) responding to IAV-
OT-I infection at d3.5 p.i. in the DLNs of WT or Batf3/ recipi-
ents. Whereas expression of early activation markers such as
CD44 andCD69 byOT-I cells aswell as ex vivo antigen-triggeredImmunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc. 401
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Figure 1. Deficiency in CD103+ RDCs Impaired Anti-IAV CD8+ Teff Cell Accumulation in the Lungs but Not DLNs
(A–D) Batf3/ and B6 mice were infected with IAV and specific CD8+ T cells in the lungs (A and B) and DLNs (C and D) were enumerated over time after tetramer
staining.
(A and C) Representative flow analyses (left) and combined NP- and PA-specific tetramer+ CD8+ T total cell numbers (right) are depicted.
(B and D) IFN-g-secreting CD8+ T cells in the infected lung (B) and DLN (D) at d7 p.i. were identified after restimulation with IAV-infected BMDCs for 5 hr in vitro
(n = 6–8 mice/genotype).
(E and F) Langerin-DTR mice were depleted of CD103+ RDCs by i.n. administration of DTx (or control PBS) followed by IAV infection. At d7 p.i., specific CD8+
T cells in the inflamed lung (E) and the responding DLN (F) were enumerated as shown in (A) and (C) (n = 7–9).
See also Figure S1.
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CD8+ T Cell Fate Decision Dictated by DC SubsetsT cell IFN-g expression were comparable in infected WT or
Batf3/ recipients, OT-I cells activated in the CD103+ RDC-defi-
cient DLNs displayed decreased CD25 and Granzyme B expres-
sion and elevated expression of CD62L (Figures 2D and S2B).
T-cell-fate-determining transcription factors T-bet and Blimp-1
were likewise decreased in OT-I cells activated within the
DLNs of infected Batf3/ recipient mice (Figures 2E and 2F;
note that the histograms for T-bet and Blimp-1 expression are
displayed on a log scale whereas the bar graphs for MFI are on
a linear scale). A more extensive analysis of a range of markers
associated with CD8+ Teff cell (or Tcm cell) differentiation in
CD8+ T cells isolated from CD103+ RDC-sufficient or -deficient402 Immunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc.DLNs including elevated CCR5 expression in the activated
OT-I cells from WT DLNs is shown in Figure S2B.
TBX21, PRDM1, and GZMB (but not IFNG) transcripts were
likewise diminished in d5 p.i. DLN non-tg activated (CD44hi)
CD8+ T cells compared to control DLN CD44hiCD8+ T cells (Fig-
ure 2G). These transcripts were expressed comparably in d5 p.i.
DLN CD44lo (nonactivated) CD8+ T cells from WT or Batf3/
donors (Figure 2G). Thus, engagement of naive CD8+ T cells
with CD103+ RDC APCs may be necessary to generate acti-
vated T cells with the properties of CD8+ Teff cells or Tem cells,
i.e., transcriptional profile, marker expression, and capacity to
migrate from the DLNs to inflammation sites.
A B C
D
G
FE
Time after infection (days)
Batf3-/-
Batf3-/- Batf3-/- Batf3-/-
Batf3-/-
Batf3-/-
Batf3-/-
Batf3-/-
Batf3-/-
Batf3-/-
(x
 1
04
)
IFN-γ
IFN-γ
O
T-
I T
 /
O
T-
I T
)
(O
T-
I T
)
Figure 2. Egress and Initial Activation of CD8+ T Cells in the DLNs of Batf3–/– Mice
(A) Tet+ CD8+ T cells in the circulation of infected Batf3/ and B6 mice were enumerated over time. A representative FACS plot evaluated at d11 p.i. is shown
(n = 8–10).
(B and C) Congenic mice that had received CFSE-labeled OT-I cells (Thy1.1) were infected with IAV-OT-I. Division (CFSE dilution) (B) and accumulation of divided
(CFSElo) (C) OT-I cells in the DLN were measured at d3.5 p.i. (n > 5).
(D–F) At d3.5 p.i., divided OT-I cells in the DLNs were examined for surface marker and Granzyme B expression directly ex vivo and for IFN-g expression after
ex vivo cognate peptide restimulation (D), T-bet (E), and Blimp-1 (F) protein expression by flow cytometry (n = 4–6).
(G) Gene expression profiles of endogenous CD8+ T cells activated in theWT (blue) orBatf3/ (red) mice. At d5 p.i., activated (CD44hi) and naive (CD44lo/) CD8+
T cells were sorted from the DLNs of infected mice. TBX21, PRDM1,GZMB, and IFNG gene expression was evaluated in total mRNA. Data represent at least two
independent experiments of cells from pools of three to five mice prior to sorting.
See also Figure S2.
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CD8+ T Cell Fate Decision Dictated by DC SubsetsCD8+ T Cells Activated in the Absence of CD103+ RDCs
Displayed Central Memory Phenotypes
In contrast to the activated CD8+ Teff cells or Tem-like T cells
stimulated by CD103+ RDCs, the activated CD8+ T cells re-sponding in the CD103+ RDC-deficient DLNs were defective in
their migration out of the DLNs during the acute phase of infec-
tion and displayed properties, i.e., marker profiles, reminiscent
of cells destined to become circulating or secondary lymphoidImmunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc. 403
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CD8+ T Cell Fate Decision Dictated by DC Subsetsorgan (SLO)-resident or homing memory CD8+ Tcm cells. We
next analyzed the properties and fate of IAV-specific CD8+
T cells present in the circulation of WT or Batf3/ mice after
recovery from acute IAV infection. We wanted to determine
whether the circulating CD8+ T cells from Batf3/ mice would
largely consist of cells displaying the phenotypic characteristics
of CD8+ Tcm cells. Accordingly, the remaining IAV-specific CD8+
T cells in recovered WT mice (which had encountered CD103+
RDCs in the DLNs during activation) would therefore be enriched
in residual CD8+ Teff or Tem-like cells. These Teff or Tem-like
cells would in turn gradually diminish in number in the circulation
over time along with the fraction of the circulating cells displaying
a CD8+ Tcm-like memory cell phenotype.
As shown in Figures 3A–3C, circulating IAV-specific CD8+
T cells from the blood of recovered Batf3/ mice analyzed at
day >60 p.i. contained a large fraction of CD62LhiCCR7hiIL-
7Rahi cells, consistent with the phenotypic characteristics of
CD8+ Tcm cells (Kaech and Wherry, 2007). The corresponding
population of circulating Tet+CD8+ T cells from recovered
WT mice exhibited a lower frequency of CD62Lhi/+ cells and
decreased expression of CCR7 and IL-7Ra as expected for a
population of antigen-specific circulating CD8+ T cells still rela-
tively enriched forCD8+Teff cells or Temcells.Whenweanalyzed
the frequency of Tet+CD8+ T cells in the circulation over time (Fig-
ure 3D), Ag-specific CD8+ T cells fromWTmice decreased in fre-
quencygradually as expectedduring thecontractionphaseof the
host response with loss of CD8+ Teff cells. Circulating Tet+CD8+
T cells from the corresponding recovered Batf3/ mice were
substantially lower in frequency initially (atd20 p.i.), decreased
more slowly over time, and were essentially unchanged between
40 and 60 days p.i. as expected for a circulating CD8+ Tcm-cell-
enriched CD8+ T cell population.
Like the acute phase of IAV infection (Figure 1), there were
fewer Ag-specific CD8+ T cells present in the lungs of recovered
Batf3/mice than in the WT mice as late as d65 p.i. (Figure 3E).
Although the number of Tet+CD8+ T cells in the DLNs was com-
parable for recovered CD103+ RDC-sufficient and -deficient
mice, the frequency of CD8+ Tcm-like (i.e., CD62LhiCCR7hi) cells
was greater in the DLNs of Batf3/ mice than in those of WT
mice (Figure 3F). Ag-specific CD8+ T cells in the DLNs of recov-
ered Batf3/ mice were able to orchestrate a CD8+ Teff cell
recall response in the lungs after adoptive transfer into congenic
WT (CD103+ RDC-containing) recipients and subsequent IAV
challenge (Figure S3).
CD11bhi RDCs are the second major migrant DC population
that can trigger antiviral naive CD8+ T cell activation in the
DLNs (GeurtsvanKessel et al., 2008; Kim and Braciale, 2009).
CD11bhi RDCs migrate in normal numbers from the lungs to the
DLNs of IAV-infected Batf3/ mice (Figures S1A and S1B). We
wished to determine whether the early activation profile and
in vivo homing of IAV-specific naive CD8+ T cells stimulated
in vitro by CD103+ or CD11bhi RDCs, respectively, mimicked
theprofileof Tcells responding in theWTorBatf3/DLNs invivo,
after adoptive transfer of cultured T cells into infected recipients
andanalysis of thedistribution of cells between the infected lungs
and the DLNs. Accordingly, naive IAV-specific TCR tg CD8+
T cells were cocultured with each of these DC populations iso-
lated from the DLNs of IAV-infected WT donors at d3 p.i. and
analyzed at 4 days of in vitro coculture for cell surface activation404 Immunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc.marker expression and expression of TBX21 and PRDM1 (Fig-
ures S4A and S4B). The phenotypic profile of the CD8+ T cells
responding to either migrant CD103+ or CD11bhi RDCs mirrored
the phenotypes of CD8+ T cells responding to IAV infection in the
WTorBatf3/DLNs, respectively (see Figures 2D–2G andS2B).
To evaluate the homing capacity of CD8+ T cells activated
by the two RDC subsets, we adoptively transferred equivalent
numbers of the CD8+ T cells stimulated in vitro by either
CD103+ or CD11bhi migrant RDCs into Thy1-mismatched recip-
ientWTmice infected 6 days before with the unrelated IAV B/Lee
strain (to exclude the possibility of effects of specific antigen
recognition on activated T cell distribution in vivo) and analyzed
the distribution of the transferred CD8+ T cells within the infected
lungs and DLNs 24 hr later. We found that naive T cells stimu-
lated with CD103+ RDCs generated activated T cells that
preferentially homed to the lungs in vivo whereas the CD8+
T cells stimulated by CD11bhi RDCs preferentially localized to
the DLNs (Figures 4A and 4B), consistent with the skewing of
T cells responding to CD103+ or CD11bhi RDCs toward CD8+
Teff or Tem-like and CD8+ Tcm-like activated cells, respectively.
Because the number of transferred cells isolated from the
respective sites (i.e., lungs or DLNs) was low, we modified this
strategy to allow amplification of the respective activated CD8+
T cell populations in vivo. In brief, after 4 days of in vitro cocul-
ture, the activated T cell populations were harvested, equivalent
cell numbers were adoptively transferred into uninfected con-
genic recipient WT mice, and the animals rested for 7 days.
The recipient mice were then infected with IAV and the accumu-
lation of responding donor CD8+ T cells in the lungs and DLNs of
infected recipients was evaluated 8 days later. As shown in Fig-
ures 4C and 4D, CD8+ T cells activated by either RDC subset
trafficked both to the lungs and to the DLNs, indicating that
both RDC subsets supported Teff cell- and Tcm cell-like differ-
entiation. However, as with the cell localization analysis 24 hr
after transfer (Figures 4A and 4B), the responding T cells did
so with markedly different efficiency, that is, the CD8+ T cells
stimulated by CD103+ RDCs preferentially migrated to the in-
fected lungswhereas the activated T cells stimulated byCD11bhi
RDCs preferentially targeted to the DLNs (Figures 4C and 4D).
Taken together, these findings suggested that CD103+ and
CD11bhi RDCs supported the differentiation of naive CD8+
T cells along distinctly different pathways characteristic of Teff
cells and Tcm cells, respectively.
Costimulatory Ligand Expression by Migrant CD103+
and CD11bhi RDCs
Although both CD103+ and CD11bhi RDCs can support naive
CD8+ T cell differentiation into Teff or Tem- and Tcm-like cells,
we found that the CD103+ RDCs were a more potent inducer
of CD8+ Teff cells during the acute phase of the IAV infection.
CD103+ RDCs appear to be intrinsically more potent APCs
than CD11bhi RDCs when presenting preprocessed peptide
antigen (migrant CD103+ and CD11bhi RDCs pulsed with syn-
thetic peptide) to naive CD8+ T cells at a low peptide dose (Fig-
ure S4C; Kim andBraciale, 2009). One explanation at least in part
accounting for the intrinsic difference in APC potency is that
CD103+ RDCs selectively express (or express an elevated level
of) one or more critical costimulatory ligands that enhance naive
IAV-specific CD8+ T cell activation. The expression of a panel of
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Figure 3. CD8+ T Cells Differentiated in the Absence of CD103+ RDCs Exhibit Central Memory-like T Cell Properties
(A–C) At >d60 p.i., circulating specific CD8+ T cells in the blood of recovered mice were analyzed for their surface expression of CD62L (A), CCR7 (B), and IL-7Ra
(C) (n = 5–8).
(D and E) Frequency of Tet+ CD8+ T cells in the circulation over time (D) and in the DLN (left panel in E) and lung (right panel in E) at d65 p.i.
(F) The frequency of CD62Lhi or CCR7hi CD8+ T cells was measured in the DLNs of recovered WT (blue) and Batf3/ (red) mice at d65 p.i. (n = 5–8).
See also Figure S3.
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CD8+ T Cell Fate Decision Dictated by DC Subsetscostimulatory ligands by the twomigrant RDC subsets was com-
parable with the notable exception of the membrane glycopro-
tein CD24 (Figure 4E). Although expressed by both RDC subsets,
CD24was expressed at10-fold higher level bymigrant CD103+
RDCs than CD11bhi RDCs both at the protein level, i.e., cell sur-
face (Figure 4E), and at the mRNA level (Figure 4F). These results
raised the possibility that differences in the capacity of CD103+
and CD11bhi RDCs to support Teff cell differentiation may have
been linked to cell surface expression of CD24 by these two
RDC subsets.
CD24 Costimulation and RDC-Dependent CD8+ T Cell
Activation
To interrogate the contribution of CD24 in the activation and
initial proliferative response of IAV-specific naive CD8+ T cells
in the DLNs, we adoptively transferred naive OT-I cells prior to
infection with IAV-OT-I and evaluated the effect of in vivo
blockade of CD24 by administration (at d1 and d3 p.i.) of block-
ing CD24 antibody (Askew and Harding, 2008; Liu et al., 1992) on
the early proliferative response and accumulation of responding
OT-I cells in the DLNs (Figure 5A). CD24 blockade resulted in
markedly reduced OT-I cell proliferation and accumulation in
the DLNs at d4 p.i. (Figure 5B). CD24 blockade likewise resulted
in a substantial decrease in the accumulation of IAV-specific
endogenous CD8+ Teff cells in the lungs at d7 p.i. (Figures 5C
and 5D) as well as substantially reduced expression of T-bet
and Blimp-1 by OT-I cells (Figure S5A) and polyclonal CD8+
Teff cells (Figures S5B and S5C).
Unlike the DLNs in infected Batf3/ mice late in infection,
in vivo CD24 blockade in infected WT mice resulted in a
decreased number of IAV-specific CD8+ Teff cells in the DLNs
at d7 p.i. (Figure 5E). This finding was not unexpected because
both CD103+ and CD11bhi RDCs express CD24 and CD11bhi
RDCs would utilize this costimulatory molecule in the activation
of naive CD8+ T cells. Indeed, in vivo CD24 blockade in infected
Batf3/ mice resulted in diminished activation and/or accumu-
lation of transferred OT-I cells in the DLNs at d4 and d7 p.i. (Fig-
ures S6A–S6D). Furthermore, the in vitro proliferation of naive
IAV-specific TCR tg CD8+ T cells in response to either migrant
CD103+ or CD11bhi RDCs was comparably inhibited by CD24
blockade (Figure 5F).
In vitro proliferation of naive CD8+ T cells (to aCD3 and aCD28)
was unaffected by CD24 blockade (Figure 6A). However, pre-
treatment of IAV-infected BMDCs with blocking CD24 antibody
prior to i.v. transfer to stimulate CD8+ T cells resulted in
a substantial decrease in the numbers of IAV-specific CD8+
Teff cells detectable in the d7 responding spleens (Figures 6B
and 6C).
To directly address whether CD24 expression level by APCs
affects the magnitude of the in vivo CD8+ T cell response, we
overexpressed CD24 in WT BMDCs by using a retrovirus vector
(Figures S6E and S6F). We first analyzed the ability of the trans-
duced infected APCs to stimulate a primary CD8+ T cell response
in vivo after i.v. adoptive transfer. Immunization with CD24-over-
expressing infected BMDCs markedly enhanced the in vivo IAV-
specific splenic CD8+ T cell response compared to control vector
transduced BMDCs (Figure S6G), and the enhanced response
was ablated when CD24-tranduced BMDCs were pretreated
with CD24 mAb prior to BMDC immunization (Figure S6G).406 Immunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc.To determine whether, like CD103+ RDCs, CD24-overex-
pressing infected BMDCs preferentially drive the activation
and/or differentiation of naive antiviral CD8+ T cells into activated
cells that preferentially homed to the lungs, we stimulated naive
IAV-specific CD8+ T cells with either infected CD24-tranduced
or control vector-transduced BMDCs in vitro for 4 days as
described for RDCs (Figures 4A and 4B) followed by the adoptive
transfer of equal numbers of the activated OT-I cells into IAV-in-
fected recipients with analysis of cell trafficking 24 hr later. Stim-
ulation of the T cells with CD24-transduced BM APCs markedly
enhanced the localization of the activated T cells to the inflamed
lungs compared to vector-transduced BMDCs (Figure 6D),
consistent with CD103+ RDCs as APCs (Figures 4A and 4B).
This analysis reinforced the view that CD24 can serve as a
costimulatory ligand in CD8+ T cell activation and further sug-
gested that the level of CD24 expression by DC APCs influenced
the subsequent differentiation of activated T cells into Teff-like
cells with the capacity to home to sites of inflammation.
CD24Controls NaiveCD8+TCell FateDecision viaRAGE
Engagement
Our observations suggest that the level of cell surface expres-
sion of the costimulatory molecule CD24 may, in part at least,
account for the difference in the ability of CD103+ and CD11bhi
migrant RDCs to support CD8+ T effector cell differentiation.
Among its several reported functions, CD24 has been demon-
strated to serve as a sensor or receptor for molecules exhibiting
damage-associated molecular pattern (DAMP) motifs, in partic-
ular HMGB1 (Chen et al., 2009). Of note, HMGB1 have been
reported to augment T cell activation through engagement of
the receptor for advanced glycation end-products (RAGE) on
T cells (Chen et al., 2008; He et al., 2013; Moser et al., 2007a).
Because IAV is a lytic virus, during infection the DAMPHMGB1
might be released from damaged and infected cells in the lungs,
captured by CD24 on the surface of CD103+ and CD11bhi RDCs,
and then transported by the migrant RDCs to the DLNs. To test
this, we analyzed cell surface HMGB1 expression on CD103+
and CD11bhi RDCs in the IAV-infected lungs and in the DLNs
after RDC migration. Like CD24 expression, CD103+ RDCs
displayed substantially higher levels of cell surface HMGB1
than did the CD11bhi RDCs both in the infected lungs (Figure 7A)
and the DLNs after RDC migration, d3 p.i. (Figure 7B). Impor-
tantly, the expression of HMGB1 on the total migrant RDCs
directly paralleled the level of expression of CD24 (Figure 7C),
consistent with the earlier finding that CD24 is a prominent
receptor for HMGB1 (Chen et al., 2009).
HMGB1 (like CD24) is minimally displayed on CD8+ T cells
(Figure S7A) whereas as reported (Moser et al., 2007a) the
RAGE receptor is prominently expressed on naive CD8+ T cells
(Figure S7A). Pretreatment of naive IAV-specific CD8+ T cells
with blocking anti-RAGE antibody prior to coculture with DCs
isolated from the DLNs at d3 p.i. resulted in significant inhibition
of the proliferative response of the IAV-specific T cells (Fig-
ure S7B). Comparable to RAGE blockade, pretreatment of the
DCs with blocking HMGB1 antibody prior to coculture with naive
IAV-specific CD8+ T cells also substantially inhibited their prolif-
eration (Figure S7B) in the fashion analogous to in vitro CD24
blockade (Figure 5F). Also, as for CD24, in vivo blockade of
HMGB1 during IAV infection by administration of blocking
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Figure 4. Trafficking and Recall Response of CD8+ T Cells Primed by CD103+ and CD11bhi RDC Subsets and Costimulatory Molecule
Expression
(A–D) CFSE-labeled naive specific Cl4 cells were stimulated in vitro with DLN-derived CD103+ or CD11bhi RDCs isolated at d3 p.i. of PR/8 IAV-infected mice
(from n = 15–20 donors/sorting). After d4, the CFSElo cells were sorted, and equivalent cell numbers were individually transferred into Thy-mismatched recipient
mice. For trafficking analyses, activated Cl4 cells (13 104/mouse) were infused into d5 p.i. B/Lee IAV-infectedmice and enumerated in the lungs and DLNs of the
recipients 24 hr p.t. (A and B). To further analyze the trafficking of the Cl4 cells after IAV challenge, in vitro activated Cl4 cells were transferred into uninfected
recipient mice and maintained in recipients for 7 days prior to infection with A/PR8 IAV. At d8 p.i., responding Cl4 cells in the lungs and DLNs of the infected
recipients were evaluated (C and D). Data represent at least two independent experiments with similar results (n = 4–6/group).
(legend continued on next page)
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IAV-specific CD8+ T cells in the DLNs (Figure 7D) and the lung
(data not shown).
To more directly assess the impact of RAGE engagement on
the localization of IAV-specific CD8+ T cells in vivo after activa-
tion, we examined the effect of RAGE blockade in cocultures be-
tween naive IAV-specific CD8+ T cells and CD103+ RDCs from
the d3 p.i. DLNs on the migration of CD8+ Teff cells to the lungs
and DLNs after adoptive transfer into infected recipients. As
shown in Figure 7E, in vitro blockade of RAGE during in vitro
stimulation of naive CD8+ T cells by CD103+ RDCs resulted in
a significant decrease in accumulation of CD8+ Teff cells in the
infected lungs and enhanced accumulation of these Teff cells
in the DLNs.
To further confirm the contribution of RAGE engagement in the
localization (and likely fate decision) of responding CD8+ T cells,
we constructed mixed bone marrow chimeras (1:1) between WT
and RAGE-deficient (Ager/) donors. After reconstitution and
IAV infection, responding Ager/ CD8+ T cells were reduced
significantly in their accumulation in the infected lungs compared
to WT T cells with only a modest, but not statistically significant,
reduction in the frequency of responding Ager/CD8+ Teff cells
in the DLNs (Figure 7F). Taken together, these results indicated
that CD24 displayed by RDCs acts as a costimulatory ligand,
at least in part through the capture of the alarmin HMGB1
(most likely within the infected lungs) and CD24 mediated its
costimulatory effect by HMGB1-dependent engagement of
RAGE on CD8+ T cells.
DISCUSSION
Two distinct subsets of migratory respiratory dendritic cells,
CD103+ RDCs and CD11bhi RDCs, serve as potent APCs trig-
gering the activation of naive CD8+ T cells in the DLN. In this
report, we provide evidence that during natural infection with
IAV, the activated CD8+ T cells stimulated after encounter with
these two RDC subsets in the DLNs in large measure exhibited
distinctly different properties. IAV-specific naive CD8+ T cells
stimulated by CD103+ RDCs primarily gave rise to activated
T cells, which efficiently exited from the DLNs during the acute
phase of infection and trafficked to the site of IAV infection to
carry out effector functions. These activated Teff cells expressed
relatively high levels of the transcriptional regulators T-bet and
Blimp-1 and display certain cell surface markers, e.g., CD25hi,
CD62Llo, and CCR5hi, characteristic of CD8+ Teff cells or Tem
cells. By contrast, those triggered by CD11bhi RDCs gave rise
to activated T cells that did not efficiently egress from the
DLNs and consequently were only modestly represented in the
IAV-infected respiratory tract during the acute phase of infection
(i.e., up to d10 p.i.). Instead, these cells accumulated in the DLNs
over this time frame. These activated T cells expressed lower
levels of the transcriptional regulators T-bet and Blimp-1 and
display certain cell surface markers, e.g., CD25lo, CD62Lhi, and(E) Expression level of markers by the RDC subsets after migration to the DLN
CD11bhi RDCs.
(F) CD24 mRNA in total RNA from the sorted CD103+ RDCs and CD11bhi RDCs
d3 p.i. Data represent three independent experiments.
See also Figure S4.
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memory CD8+ T cells, in particular Tcm cells. We also provide
evidence that the costimulatory molecule CD24, which is differ-
entially displayed on the surface of these two RDC subsets, was
one important factor in facilitating the differentiation of naive
CD8+ T cells into effector-like or memory-like CD8+ T cells. Our
results further suggested that CD24 differentially displayed on
the surface of these two DC subsets carried out its costimulatory
function by presenting HMGB1 to RAGE on the responding
T cells. Thus, CD24 displayed byDCAPCs through its interaction
with RAGE on CD8+ T cells contributed to the fate decision of the
responding CD8+ T cells.
DC subsets with different intrinsic properties have been impli-
cated (along with cytokine milieu) as critical in dictating the
outcome of naive T cell differentiation, i.e., generation of various
Teff cell subsets and/or the transition into memory T cells (Belz
et al., 2002; Sallusto and Lanzavecchia, 2000). More recent
studies analyzing the fate decision of naive CD8+ T cells after
antigenic stimulation, i.e., effector cell versus memory cell differ-
entiation, have focused on the duration and/or strength of the
initial antigenic stimulus provided by the APC, i.e., the summa-
tion of signals emanating both from TCR engagement and co-re-
ceptor-ligand interactions (Haring et al., 2006; Iezzi et al., 1998;
Joshi et al., 2007). Accordingly, the greater the strength and/or
duration of the antigenic stimulus, the more likely the responding
CD8+ T cells will display an effector T cell-like profile including
upregulated expression of Blimp-1 and T-bet—two transcrip-
tional regulators critical for the differentiation of naive CD8+
T cells into short-lived Teff cells capable of egress from the
DLNs to sites of infection (Kallies et al., 2009). Our findings
confirm and extend these earlier results and suggest that the
fate decision for naive CD8+ T cell differentiation into effector
or memory phenotype cells, in part at least, resides in the prop-
erties of the distinct DC subsets acting as APCs with the potent
stimulus provided by the CD24hiCD103+ RDCs supporting Teff
cell differentiation and the weaker stimulus provided by the
CD24loCD11bhi RDCs driving the formation of Tcm-like cells.
However, CD24 expression on CD11bhi RDCs is heterogeneous
and a small fraction of CD11bhi RDCs are CD24hi (data not
shown), perhaps accounting for the small number of lung-hom-
ing Teff cells in infected CD103+ RDC-deficient mice.
CD24 is a cell surface glycosyl-phosphatidylinositol (GPI)-
anchored protein expressed on a variety of cell types, notably
B lymphocytes (Hardy et al., 1984), and a variety of APCs
including DCs (Askew and Harding, 2008; Martinez del Hoyo
et al., 2002). CD24 was initially identified as a costimulatory
molecule functioning primarily on APCs to costimulate T cell acti-
vation during antigen-specific T cell responses via a CD28-inde-
pendent costimulatory pathway (Wu et al., 1998). More recently,
CD24 was demonstrated to also serve as a stress sensor or re-
ceptor recognizing and binding certain damage-associated mo-
lecular patterns (DAMPs), notably HMGB1 (Chen et al., 2009).
Our results on the association between HMGB1 and CD24 onis represented as the ratio of MFI of CD103+ RDCs relative to the MFI of
isolated from the pooled DLNs (from n = 15–20 mice/sorting) was analyzed at
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Figure 5. Impact of CD24 Blockade on Anti-IAV CD8+ T Cell Responses In Vivo
(A) Tomonitor the effect of CD24 blockade on early events during T cell activation in vivo, CFSE-labeled OT-I cells were transferred into B6WTmice, infected with
PR8-OT-I IAV 24 hr p.t. These infected recipients were infused i.p. with aCD24 mAb or IgG mAb at both d1 and d3 p.i.
(B) Cell division (left) and the fraction (%) (middle) and total numbers (right) of divided OT-I cells were enumerated (n = 4–5 recipients).
(C–E) At d7 p.i., the frequency and total numbers of IAV-responding lung and DLN CD8+ T cells was determined by IFN-g secretion after infected BMDC re-
stimulation ex vivo for 5 hr (C) and direct ex vivo analysis of tet+ (NP and PA) CD8+ T cells in the lungs (D) and DLNs (E). Data represent at least three individual
experiments (n = 4–5 mice/group).
(F) Requirement of CD24-expressed RDC subsets for full expansion of naive CD8+ T cells. CFSE-labeled naive Cl4 cells were cocultured with sorted CD11bhi or
CD103+ RDCs from d3 p.i. DLNs (n = 15–20mice/sorting) in the presence (filled in red) or absence (white lines) of aCD24mAb. At d4, the extent of cell division (left)
and total divided Cl4 cells (right) were examined. Data represent at least three independent experiments.
See also Figure S5.
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Figure 6. Elevated CD24 Expression by DCs Enhances CD8+ T Cell Response and Promotes Lung Homing
(A) Effect of in vitro CD24 blockade on aCD3-CD28 Ab-stimulated proliferation of dye-labeledCl4 cells or polyclonal CD8+ T cells (data not shown) as determined
by CFSE dilution at d3 of culture. Data are representative of three independent experiments.
(B and C) IAV-infected BMDCswere treated with blocking CD24mAb prior to transfer into naivemice. At d7 after infected BMDC transfer, the frequency and total
number of tet+ CD8+ T cells (B) and IFN-g-secreting CD8+ T cells after ex vivo peptide restimulation (C) in the spleens were determined.
(D) BMDCs overexpressing CD24 by retrovirus transduction (pCD24; Figures S6E and S6F and control vector BMDCs) were pulsed with OT-I peptide prior to
coculture with naive OT-I cells (Thy1.1) for 4 days. Activated OT-I cells (5 3 104/mouse) were then transferred into d5 p.i. WT IAV-infected mice (Thy1.2).
Accumulation of OT-I cells in the lungs and DLNs was evaluated 24 hr later.
Data in (B)–(D) represent at least three independent experiments (n = 4–5 mice/group). See also Figure S6.
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consistent with these earlier findings. More importantly, our find-
ings suggest a confluence of the roles of CD24 as a T cell costi-
mulatory molecule and stress sensor through its ability to bind
HMGB1 and deliver this cargo to RAGE on naive T cells. It
should, however, be noted that whereas these findings suggest
the importance of the HMGB1-CD24 complex as a regulator of
T cell activation, other defined (e.g., HSPs) or suggested (e.g.,
S100 protein) CD24 DAMP ligands could also contribute to cos-
timulatory effect of CD24. Further, RAGE blockade or deficiency
in T cells does not fully recapitulate the impact of CD103+ RDC
loss on the response of naive CD8+ T cells, suggesting a role
for other T cell DAMP receptors in this fate decision (see below).
Along with CD24, HMGB1 has been reported to interact with
several other DAMP sensors including several TLRs and the
RAGE. RAGE is expressed on a variety of cell types including
DCs and T cells (Alexiou et al., 2010). Earlier studies on the
role of RAGE in T cell activation demonstrated that RAGE
blockade (Dumitriu et al., 2005; Moser et al., 2007b) or RAGE
deficiency in T cells (Chen et al., 2008; Moser et al., 2007a) re-
sulted in diminished T cell activation and proliferation. Therefore,
we considered RAGE to be an attractive candidate receptor for
the HMGB1-CD24 complex displayed by the migrant RDCs.
Our findings on the impact of RAGE blockade in vitro on the sub-
sequent in vivo migration properties of activated CD8+ T cells as410 Immunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc.well as the diminished migration of RAGE-deficient activated
CD8+ T cells into the IAV-infected lungs and the mixed bone
marrow chimeras point to the importance of RAGE and
RAGE engagement by HMGB1 in CD8+ T cell activation and dif-
ferentiation. However, we cannot exclude a complementary or
synergistic role of other sensors, e.g., TLRs, in regulating or aug-
menting RAGE-mediated HMGB1-dependent signaling events.
Also, RAGE-deficient mice have been reported to display
enhanced resistance to IAV infection (van Zoelen et al., 2009;
unpublished data). This outcome most likely reflects the effect
of RAGE deficiency on the response of one or more cell types
in the lungs to IAV infection, probably resulting in decreased
pulmonary inflammation and injury.
In summary, we have explored the function of two distinct DC
subsets responding in the respiratory tract to virus infection in
the generation and properties (i.e., differentiation) of virus-spe-
cific CD8+ T cells induced in response to these specialized
APC subsets. Our findings suggest a ‘‘division of labor’’ between
these two RDC subsets, which allow them to balance in kind and
in time the nature of the antiviral CD8+ T cell response after their
encounter with naive CD8+ T cells in the DLNs. This difference in
the function of the two DC subsets reflects a quantitative differ-
ence in the level of expression of the CD24-HMGB1 complex on
these two DC subsets and the interaction of this complex with
RAGE on the responding T cells.
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Figure 7. CD24 Controls Naive CD8+ T Cell Fate Decision via RAGE Engagement
(A–C) RDC subsets isolated from the lung (A) and DLN (B) at d3 p.i. were stained for cell-bound HMGB1. Shown are representative flow cytometric plots (left in A)
and MFI (right in A and B; n = 4–5 mice/group). Migrant RDCs in the DLN at d3 p.i. were stained simultaneously with control and mAbs specific for HMGB1 and
CD24 (C). Data are representative of three independent experiments.
(D) CFSE-labeled OT-I cells were transferred into naiveWTmice, which were subsequently infected with PR/8-OT-I IAV. aHMGB1 Ab was administered i.n. at d1
and d3, p.i. OT-I cell proliferation in the DLN was examined at d4 p.i. (n = 4–6 mice/group).
(E) Naive Cl4 cells were cocultured for 4 days with DLN-derived CD103+ RDCs in the presence or absence of aRAGE Ab. Activated Cl4 cells (53 104/mouse)
were transferred into d6 p.i., B/Lee-infected mice and Cl4 cell accumulation in the lungs and DLNs was evaluated 24 hr later (n = 4–5 mice/group). Cl4 cells
activated by CD11bhi RDCs were used as controls.
Data in (D) and (E) represent at least two independent experiments.
(F) Mixed BM chimeric mice between WT and Ager/marrows (1:1) were generated and infected with PR/8. IAV-specific CD45 congenic memory CD8+ T cells
were identified in the lungs and DLNs (left) and enumerated (right) at d60 p.i. Data represent at least two independent experiments (n = 4–6/expt).
See also Figure S7.
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Mice, Virus, and Infection
FemaleC57BL/6 (B6, H-2b) andBALB/c (H-2d)mice ranging from8 to 12weeks
old were purchased from the National Cancer Institute. Batf3/ mice on a
129S6/SvEv background were previously generated (Hildner et al., 2008).Batf3/ mice were backcrossed at least ten generations to the C57BL/6
background prior to use in our experiments. Details of the additional mice
employed in this study and viral infection are provided under Supplemental
Experimental Procedures. All animal experiments were performed in accor-
dance with protocols approved by the University of Virginia Animal Care and
Use Committee.Immunity 40, 400–413, March 20, 2014 ª2014 Elsevier Inc. 411
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CD8+ T Cell Fate Decision Dictated by DC SubsetsAntibodies, Flow Cytometry Analysis, and Intracelluar Staining
Monoclonal antibodies (mAb) were purchased from BD Biosciences or
eBioscience (unless otherwise stated), and clones were described in detail
previously (Kim and Braciale, 2009). H-2Db tetramers were purchased from
the Trudeau Institute. Anti-mouse CD16/32 used for Fc receptor blocking
was isolated and purified in our laboratory. For biotinylated mAbs, samples
were incubated with streptavidin (SA)-RPE, SA-APC, or SA-APC-Cy7.
In Vitro DC:T Cell Cocultures, Antibody Blockade, and Adoptive
Transfer
ForDC:T cell cultures, 13104DCsand13105Tcellswere cultured in a volume
of 200ml in round-bottomed 96-well plates (Corning) and incubated at 37C for
4 days in RPMI 1640media supplementedwith 10%heat-inactivated FCS, 1%
sodiumpyruvate, 2mML-glucose, 20mMHEPES, 5mMb-mercaptoenthanol,
and 100mg/ml gentamycin (all from Invitrogen). Peptide-coatedDCswere pre-
pared by incubating isolatedDCswith 1mMpeptide (HA533-541, H-2
d) for 1 hr at
37C, followed by 23 washes to remove any free peptides prior to coculture
with T cells. To interfere with ligand/receptor interaction in the DC:T cell cocul-
ture, blocking mAbs at a final concentration of 20 mg/ml were included in the
media. Monoclonal Abs used were M1/69 (anti-mouse CD24, BioLegend),
polyclonal rabbit anti-HMGB1 (Sigma), and polyclonal goat anti-mouse
RAGE (R&D Systems). For in vivo blockade of HMGB1, aHMGB1 (Sigma)
was i.n. instilled (80 mg/mouse) at the indicated days after infection.
Purified splenic naive OT-I or HA-specific CD8+ TCR Tg Cl4 CD8+ cells
were labeled with carboxyfluorescein diacetate succinimidyl ester (CFDA-
SE; Molecular Probes) as previously described (Lawrence and Braciale,
2004). A graded number of CFSE-labeled T cells as indicated were i.v. injected
into the tail vein of Thy-mismatched congenic mice (Thy1.2) at indicated time
points. Recipient mice were then infected with influenza virus 24 hr later.
Quantitative Real-Time PCR
Total RNA was extracted from tissues via Trizol (Invitrogen), according to the
manufacturer’s instructions. cDNA was prepared with SuperScript II Reverse
Transcriptase (Invitrogen) from 2 mg total RNA via random hexamers. Real-
time PCR was performed in an ABI PRISM cycler (Life Technologies) with a
SYBR Green PCR kit from Applied Biosystems (Life Technologies) with the
following predesigned primer sets: GZMB, TBX21, PRDM1, and IFNG (all pur-
chased from Applied Biosystems). Expression levels of evaluated genes were
calculated with the comparative DCt method, and relative abundance was
quantified with the 2DCt method.
Retroviral Constructs and Transductions
For overexpression of CD24 (HSA), the retroviral vector pMIG-R1 (a kind
gift from T. Bender, University of Virginia, VA) was used to construct pMIG-
CD24-IRES-GFP according to previous descriptions (Fahl et al., 2009). Details
of procedures are provided under Supplemental Experimental Procedures.
Statistics
A two-tailed unpaired Student’s t test was used to analyze differences in mean
values between groups. These statistical analyses were performed with the
GraphPad Prism3 Software Program for Macintosh. Results are expressed
as means ± SEM. Values of p < 0.05 were considered statistically significant
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2014.02.004.
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